Ryan Jones is the co-founder and CEO of Florence Healthcare, a leading clinical trial software company.
The Covid-19 vaccine studies showed that clinical trials must find more participants, especially diverse participants, and one way that might help is by going multinational. Technology made it possible for research sponsors to communicate and share documents and data with multiple sites around the world, even when travel was restricted.
Holding trials across multiple countries doesn’t just help vaccine trials—it can also help clinical trials that have strict enrollment requirements, like biomarker-driven oncology trials. Additionally, expanding clinical trials benefits patients living in low- or middle-income countries, who often have fewer treatment options.
Going multinational is only possible, however, if sponsors and contract research organizations (CROs) have consistent and always-on remote access to their research sites. This is where technology plays a vital role. Software can help sponsors perform remote monitoring,